Efficacy of EPs 7630 compared to placebo in the treatment of acute bronchitis
Completed
- Conditions
- Acute bronchitisRespiratoryBronchitis
- Registration Number
- ISRCTN60790910
- Lead Sponsor
- ISO Arzneimittel GmbH & Co KG (Germany)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 205
Inclusion Criteria
Patients who met the following inclusion criteria were suitable for the trial:
1. Aged greater than or equal to 18 years, acute bronchitis, duration of complaints less than 48 hours, and total score of bronchitis-specific symptoms greater than or equal to 5 points
2. In addition patients had to sign an informed consent
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ot provided at time of registration
- Secondary Outcome Measures
Name Time Method ot provided at time of registration